{"title":"The influence and mechanism of gut microbiota on spermatogenesis.","authors":"Xinxing Zhou, Zhongli Ge, Xinyue Yang, Yujuan Liu, Yaoyun Li, Luning Chen, Liqiong Lv, Guanghui Chen","doi":"10.1007/s10565-026-10168-1","DOIUrl":null,"url":null,"abstract":"<p><p>Gut microbiota (GM) serves several functions in host, including immunological modulation, maintaining intestinal epithelial cell barrier and defending against pathogen invasion. Previous research has demonstrated that GM could regulate distal organs such as gut-brain and gut-liver axis. Recently, a rising number of researchers have discovered the substantial link between GM alteration and spermatogenesis disorder in male. This review highlights the phenomena of sperm production abnormalities caused by GM dysbiosis and the putative molecular pathways. Microbiota dysbiosis could lead to abnormal sperm production through multiple pathways. For example, the metabolic disturbance of vitamins impairs meiosis and spermatogenesis, upregulated miR-211-5p of extracellular vesicles inhibits meiosis and damages spermatogenesis, abnormal sphingolipid metabolite affects spermatogenic cell apoptosis, decreased short-chain fatty acid level causes inflammation and damages testicular tissue and reduced androgen level, resulting in spermatogenesis disorder. In addition, this review highlights therapeutic strategies, such as the administration of vitamins, probiotics, and prebiotics, for the treatment of spermatogenesis disorders associated with GM dysregulation. These insights underscore the importance of targeting the GM to preserve sperm quality and improve male reproductive health, offering promising future directions for the treatment of spermatogenic dysfunction and infertility.</p>","PeriodicalId":9672,"journal":{"name":"Cell Biology and Toxicology","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2026-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124844/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Biology and Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10565-026-10168-1","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Gut microbiota (GM) serves several functions in host, including immunological modulation, maintaining intestinal epithelial cell barrier and defending against pathogen invasion. Previous research has demonstrated that GM could regulate distal organs such as gut-brain and gut-liver axis. Recently, a rising number of researchers have discovered the substantial link between GM alteration and spermatogenesis disorder in male. This review highlights the phenomena of sperm production abnormalities caused by GM dysbiosis and the putative molecular pathways. Microbiota dysbiosis could lead to abnormal sperm production through multiple pathways. For example, the metabolic disturbance of vitamins impairs meiosis and spermatogenesis, upregulated miR-211-5p of extracellular vesicles inhibits meiosis and damages spermatogenesis, abnormal sphingolipid metabolite affects spermatogenic cell apoptosis, decreased short-chain fatty acid level causes inflammation and damages testicular tissue and reduced androgen level, resulting in spermatogenesis disorder. In addition, this review highlights therapeutic strategies, such as the administration of vitamins, probiotics, and prebiotics, for the treatment of spermatogenesis disorders associated with GM dysregulation. These insights underscore the importance of targeting the GM to preserve sperm quality and improve male reproductive health, offering promising future directions for the treatment of spermatogenic dysfunction and infertility.
期刊介绍:
Cell Biology and Toxicology (CBT) is an international journal focused on clinical and translational research with an emphasis on molecular and cell biology, genetic and epigenetic heterogeneity, drug discovery and development, and molecular pharmacology and toxicology. CBT has a disease-specific scope prioritizing publications on gene and protein-based regulation, intracellular signaling pathway dysfunction, cell type-specific function, and systems in biomedicine in drug discovery and development. CBT publishes original articles with outstanding, innovative and significant findings, important reviews on recent research advances and issues of high current interest, opinion articles of leading edge science, and rapid communication or reports, on molecular mechanisms and therapies in diseases.